Drugs Made In America Acquisition Corp.
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DMAA and other ETFs, options, and stocks.About DMAA
Drugs Made In America Acquisition Corp. is a blank check company, which engages in the provision of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on May 23, 2024 and is headquartered in Fort Lauderdale, FL.
DMAA Key Statistics
Stock Snapshot
The current Drugs Made In America Acquisition Corp.(DMAA) stock price is $10.35, with a market capitalization of 346.98M. The stock trades at a price-to-earnings (P/E) ratio of 61.48.
As of 2025-12-12, Drugs Made In America Acquisition Corp.(DMAA) stock has fluctuated between $10.35 and $10.35. The current price stands at $10.35, placing the stock 0.0% above today's low and 0.0% off the high.
Drugs Made In America Acquisition Corp.(DMAA) shares are trading with a volume of 2.83K, against a daily average of 14.06K.
In the last year, Drugs Made In America Acquisition Corp.(DMAA) shares hit a 52-week high of $10.37 and a 52-week low of $9.95.
In the last year, Drugs Made In America Acquisition Corp.(DMAA) shares hit a 52-week high of $10.37 and a 52-week low of $9.95.